Acquired by Ovid Therapeutics in January of 2022, Transporter Therapeutics was founded by a team of transformative leaders in central nervous system (CNS) disease biology, drug resistance, clinical drug development and translational medicine. We focus on creating new chemical entities (NCE) that address under-served CNS disease, drive durable clinical responses and diminish suffering for patients across the globe. To achieve this, we leverage discoveries in solute carriers and inhibitory ligand gated ion channel protein biology that contribute to or drive the development and persistence of disease. To make these discoveries, Transporter Therapeutics harnesses novel drug discovery platforms and drug delivery systems to improve treatment outcomes.
Company Details
- Founded
- -
- Address
- Under-Served Cns Disease
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.transportertx.com
Transporter Therapeutics (Acquired By Ovid Therapeutics 2022) Questions
Transporter Therapeutics (Acquired By Ovid Therapeutics 2022)'s website is https://www.transportertx.com
Transporter Therapeutics (Acquired By Ovid Therapeutics 2022)'s LinkedIn profile is https://www.linkedin.com/company/transportertx
Transporter Therapeutics (Acquired By Ovid Therapeutics 2022)'s industry is
Pharmaceutical Manufacturing
Transporter Therapeutics (Acquired By Ovid Therapeutics 2022)'s top competitors are
Vertex Pharmaceuticals,
Apex Pharma Talent,
Soleno Therapeutics, Inc.,
Syon Solutions Inc,
Convey Bio,
Carbon Biosciences,
Corporate Connections International Inc.,
Madrigal Pharmaceuticals,
Vyne Therapeutics Inc.,
Ovid Therapeutics.
Transporter Therapeutics (Acquired By Ovid Therapeutics 2022)'s categories are Pharmaceutical Manufacturing
Transporter Therapeutics (Acquired By Ovid Therapeutics 2022)'s founding year is 2021
